MENU
Articles by #hashtag

pharmaceuticalindustry

54 hits

Egis Inaugurates Distribution Center Next to Budapest

D&T
Oct 12, 2026

Hungarian pharmaceutical company Egis, owned by France's Servier, inaugurated a central distribution warehouse in Fót, on the outskirts of the capital, on Monday. The warehouse, with capacity for 30,000 palettes of product, was inaugurated in the HelloParks industrial park. CEO Csaba Poroszlai noted that Egis is market leader in Hungary in terms of number of […]

Pharma Sector as Example of Knowledge-Based Economy

D&T
Oct 2, 2026

The government aims to build a knowledge-based economy and the strategically important Hungarian pharmaceutical industry can serve as an example in this regard, Economy and Energy Minister István Kapitány said at a conference of the Hungarian National Association of Pharmaceutical Manufacturers (MAGYOSZ) on Friday. The minister emphasized that the Hungarian pharmaceutical industry is export-oriented and […]

Richter CEO: Company on Course Planned by Management

D&T
Aug 8, 2026

“Richter is right on track with management’s expectations and has achieved solid profitability at an unchanged exchange rate,” CEO Gábor Orbán said during an online briefing on Friday to review the first-half results of the pharmaceutical company Richter Gedeon Nyrt. He added that the significant exchange rate impact comes as no surprise to anyone, as […]

Richter Gedeon Announces Mass Layoffs

D&T
Jun 29, 2026

Hungarian pharmaceutical company Richter Gedeon has announced mass layoffs of more than 30 people over a 30-day period, the company announced in a statement on Monday. Richter is quoted by MTI to have said that the planned reductions will affect pharmaceutical manufacturing, particularly active ingredient manufacturing. Maintaining the competitiveness of active ingredient manufacturing is a […]

PHOENIX Pharma Inaugurates HUF 8 Bn Logistics Center

D&T
Jun 19, 2026

PHOENIX Pharma on Friday inaugurated a 6,550sqm logistics center in Győr (NW) Hungary built with investing HUF 8 billion of its own funds, MTI reports. PHOENIX Pharma board chairman Tamás Kaló said the center, established as a greenfield investment, serves the pharmacies, hospitals and the population of Győr-Moson-Sopron, Komárom-Esztergom, Veszprém and Fejér Counties. The base […]

Richter, Hetero Labs Partner on Generic of Ozempic

D&T
Jun 10, 2026

Hungarian pharmaceutical company Gedeon Richter announced the signing of a global collaboration agreement with Indian peer Hetero Labs on the joint development, registration and commercialization of a semaglutide injection, a generic of the anti-diabetic drug Ozempic, the Hungarian company has announced on thew website of the Budapest Stock Exchange. The agreement combines the companies’ complementary […]

Gedeon Richter Earnings Slip as Financial Gains Narrow

D&T
May 12, 2026

First-quarter net income of Hungarian pharmaceutical company Gedeon Richter fell 4% year-on-year to HUF 65.3 billion as operating profit stagnated and net financial gains narrowed, an earnings report published ahead of the opening bell on Tuesday shows. Revenue edged down 2% to HUF 220.2 billion, impacted by the continuing trend of the weaker dollar and […]

Pioneering R&D Investment by Hungarian Medicine Firm

D&T
Mar 30, 2026

Hungarian nuclear medicine supplier Medi-Radiopharma is launching an R&D investment to develop a pioneering manufacturing technology, the Hungarian Investment Promotion Agency (HIPA) reports. Supported by the HIPA, the EUR 6.56 million investment aims to introduce an industry-scale, automated technology to produce radiopharmaceuticals, that is faster, and more efficient and accurate than the currently dominant manual, […]

GSK, a Global Company of Responsible Business

D&T
Mar 28, 2026

GlaxoSmithKline Biologicals Ltd., based in Gödöllő, about 30 kilometers northeast of Budapest, serves as one of the world’s centers of excellence for vaccine manufacturing. The Gödöllő site has been producing vaccine components, bulk antigen and carrier protein since 2002, building on a 50-year scientific competence heritage in Hungary. The site produces the raw materials for […]

Viatris Komárom-Mylan Hungary to Expand Capacity

D&T
Mar 21, 2026

US-owned pharmaceutical company Viatris Komárom-Mylan Hungary will invest over EUR 16 million at its base in Komárom (northwest of Budapest), expanding packaging and quality control capacity. Mylan Hungary Ltd., part of the American Viatris group, is one of the key centers in the European packaging and quality control network. At its Komárom site, the company […]

New Pharmaceutical Industry Investment in Hungary

D&T
Mar 6, 2026

Denmark-based Xellia Pharmaceuticals is investing EUR 70.85 million in Szigetszentmiklós, south of Budapest, further strengthening Hungary's role in the European healthcare and antibiotic supply chain. The development aims to create a modern, automated pharmaceutical manufacturing plant and promises create 91 new high value-added jobs. Headquartered in Copenhagen, Xellia Pharmaceuticals is a specialty pharmaceutical company focused […]

Richter Hormone Replacement Therapy Drug Near Approval

D&T
Jan 30, 2026

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the approval of Hungarian pharmaceutical company Gedeon Richter's drug FYLREVY as hormone replacement therapy for estrogen deficiency symptoms, Richter said on Friday. The European Commission will review the CHMP recommendation for a final decision […]

Egis Inaugurates HUF 30 Bn Active Ingredient Plant

D&T
Nov 20, 2025

Egis Pharmaceuticals Ltd. has unveiled one of the most significant developments in its 112-year history in Budapest. The company will manufacture the active ingredient for a globally leading product at its new HUF 30 billion plant, which was financed from its own resources, the company told MTI on Thursday. According to the announcement, what makes […]

Roche Cooperation Agreement with the University of Szeged

D&T
Nov 17, 2025

The biotechnology and pharmaceutical company Roche and the University of Szeged (SZTE) have agreed to support research, development, and educational activities and to implement joint innovation projects. The agreement was signed on Monday during the university's Innovation Day in the southeastern Hungarian city of Szeged. Judit Fendler, Chancellor of SZTE, said that in addition to […]

Richter Earnings Slip as Financial Loss Weighs

D&T
Nov 6, 2025

Net income of Hungarian pharmaceutical company Gedeon Richter fell 7% year-on-year to HUF 163.3bn in Q1-Q3, dropping on a financial loss, an earnings report posted ahead of the opening bell on Thursday shows. Revenue rose 7% to HUF 680.2 billion and operating profit climbed 8% to HUF 204.5 billion. A net financial loss of HUF […]

© Copyright 2026 Duax Kft. –  All rights reserved.
sun
Diplomacy & Trade
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.